Redeye: Ngenic - Growth vs Cash Management

Redeye is encouraged by the sales beat in the quarter and notes that the high demand accelerated throughout the quarter. At the same time, the operating loss was higher than we expected. We think the company needs to decide between continuing to invest for growth and raising capital, or focusing on cash flow. We argue that the risk has increased and reduce our fair value range.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Source: MFN

Det verkar som att du använder en annonsblockerare

Om du är prenumerant behöver du logga in för att fortsätta. Vill bli prenumerant kan du läsa Di Digitalt för 197 kr inkl. moms de första 3 månaderna.